SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001724521-24-000034
Filing Date
2024-01-30
Accepted
2024-01-30 08:17:44
Documents
18
Period of Report
2024-01-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rcus-20240129.htm   iXBRL 8-K 35647
2 EX-99.1 ex991.htm EX-99.1 34526
7 image_0.jpg GRAPHIC 10678
8 image_1.jpg GRAPHIC 18152
  Complete submission text file 0001724521-24-000034.txt   258813

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20240129.xsd EX-101.SCH 2146
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rcus-20240129_def.xml EX-101.DEF 2842
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20240129_lab.xml EX-101.LAB 26183
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20240129_pre.xml EX-101.PRE 14134
19 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20240129_htm.xml XML 2714
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 24575943
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)